Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China

Published:2019-02-22 Issue:6 Volume:145 Page:1517-1528
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Deng Mei¹²,Chen Hui‐Hui¹³,Zhu Xuan¹³,Luo Meng¹³,Zhang Kun¹³,Xu Chun‐Jing¹³,Hu Kai‐Min¹,Cheng Pu⁴,Zhou Jiao‐Jiao¹³,Zheng Shu¹³,Chen Yi‐Ding¹³^ORCID

Affiliation:

1. Department of Surgical OncologyThe Second Affiliated Hospital, Zhejiang University School of Medicine Zhejiang Hangzhou China

2. Department of RadiotherapyAffiliated Hospital, Guilin Medical University Guilin Guangxi China

3. The Key Laboratory of Cancer Prevention and InterventionChina National Ministry of Education Zhejiang Hangzhou China

4. Department of GynecologyThe Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China

Funder

Natural Science Foundation of Zhejiang Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32184

Reference53 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Familial Breast Cancer

3. Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

4. Meta-Analysis ofBRCA1andBRCA2Penetrance

5. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care;Clinical Oncology;2024-08

2. Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China;Journal of Cancer Research and Clinical Oncology;2024-06-25

3. Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants;Breast Cancer Research and Treatment;2024-06-20

4. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area;BMC Cancer;2024-04-02

5. Racial and socioeconomic disparities in triple-negative breast cancer treatment;Expert Review of Anticancer Therapy;2024-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3